Specification
Description
Cholesteryl hemisuccinate is a with hepatoprotective an anticancer activity. Cholesteryl hemisuccinate inhibits Acetaminophen (AAP, HY-66005) hepatotoxicity, and prevents AAP-induced hepatic apoptosis and necrosis. Cholesteryl hemisuccinate inhibits DNA polymerase and DNA topoisomerase to inhibit DNA replication and repair and cell division. Thus, Cholesteryl hemisuccinate inhibits tumor growth.
Synonyms
Cholesteryl hydrogen succinate
IUPAC Name
4-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid
Canonical SMILES
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)CCC(=O)O)C)C
InChI
InChI=1S/C31H50O4/c1-20(2)7-6-8-21(3)25-11-12-26-24-10-9-22-19-23(35-29(34)14-13-28(32)33)15-17-30(22,4)27(24)16-18-31(25,26)5/h9,20-21,23-27H,6-8,10-19H2,1-5H3,(H,32,33)/t21-,23+,24+,25-,26+,27+,30+,31-/m1/s1
InChI Key
WLNARFZDISHUGS-MIXBDBMTSA-N
Boiling Point
586.0±43.0 °C (Predicted)
Density
1.06±0.1 g/cm³ (Predicted)
Solubility
Chloroform: 10 mg/mL
Appearance
A crystalline solid
Application
Cholesteryl hemisuccinate serves as a versatile compound with diverse applications in biochemical and pharmacological studies. It is primarily used as a detergent to replace cholesterol in protein crystallography, which aids in the structural analysis of proteins. Its function extends to stabilizing unilamellar vesicles and liposomes, essential for various drug delivery systems involving anticancer drugs, antibiotics, and oligonucleotides. Additionally, cholesteryl hemisuccinate exhibits anticancer properties by inhibiting the growth of certain leukemia cells. It also acts as an emulsifying agent, facilitating the solubilization of proteins, such as chemokine receptor 1 and erythrocyte ghosts, enhancing their study and application in research and therapeutic contexts.
Storage
Powder-20°C, 3 years; 4°C, 2 years; In solvent-80°C, 6 months; -20°C, 1 month.
Hydrogen Bond Acceptor Count
4
Hydrogen Bond Donor Count
1
Isomeric SMILES
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)CCC(=O)O)C)C
Monoisotopic Mass
486.37091007
pKa
4.40±0.17 (Predicted)
Shipping
Room temperature
Storage Conditions
-20 °C
Topological Polar Surface Area
63.6 Ų